NCT06896682
- Conditions
- Postbariatric Hypoglycemia
- Locations
-
- Esbjerg Hospital Esbjerg, Denmark
Clinical trial condition
Postbariatric Hypoglycemia
Explore clinical trials studying Postbariatric Hypoglycemia. Study availability and eligibility vary by location and protocol.
6 public trials
1 recruiting study
Postbariatric Hypoglycemia trial results
NCT07029412
- Conditions
- Postbariatric Hypoglycemia
- Locations
-
- MBX Biosciences Investigational Site Aurora, Colorado, United States
- MBX Biosciences Investigational Site Morehead City, North Carolina, United States
- MBX Biosciences Investigational Site Knoxville, Tennessee, United States
- MBX Biosciences Investigational Site San Antonio, Texas, United States
Completed
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
NCT05721729
- Conditions
- Postbariatric Hypoglycemia
- Locations
-
- Stanford Palo Alto, California, United States
- University of Colorado / Anschutz Medical Campus Aurora, Colorado, United States
Completed
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
NCT06036784
- Conditions
- Postbariatric Hypoglycemia
- Locations
-
- MBX Biosciences Investigational Site Chula Vista, California, United States
Completed
Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects
NCT05541939
- Conditions
- Postbariatric Hypoglycemia
- Locations
-
- Stanford Palo Alto, California, United States
- University of Colorado / Anschutz Medical Campus Aurora, Colorado, United States
NCT03373435
- Conditions
- Postbariatric Hypoglycemia
- Locations
-
- Stanford University Palo Alto, California, United States
- University of Colorado, Denver Aurora, Colorado, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Duke Early Phase Clinical Research Durham, North Carolina, United States